Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Michael Grayling.

Newcastle AuthorsTitleYearFull text
Professor Andrew Fisher
Professor Helen Hancock
Professor James Wason
Dr Michael Grayling
Dr Joanne Lally
et al.
Extracorporeal Photopheresis (ECP) in the Treatment of Chronic Lung Allograft Dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK)2024
Dr Michael Grayling
Sylvia Zhang
A Bayesian approach to pilot-pivotal trials for bioequivalence assessment2023
Samuel Sarkodie
Professor James Wason
Dr Michael Grayling
A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation2023
Andrew Bryant
Dr Michael Grayling
Professor Dawn Craig
Professor Luke Vale
Residual Disease after Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias2023
Andrew Bryant
Eugenie Johnson
Dr Michael Grayling
Shaun Hiu
Dr Ahmed Elattar
et al.
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis2023
Dr Heather Lambert
Shaun Hiu
Dr Malcolm Coulthard
Professor John Matthews
Dr Eva-Maria Holstein
et al.
The Infant KIdney Dialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant Hemodialysis Device2023
Dr Michele Castelli
Dr Michael Grayling
The prevalence and social determinants of multimorbidity in South Africa2023
Luke Ouma
Dr Michael Grayling
Professor James Wason
Dr Haiyan Zheng
Bayesian modelling strategies for borrowing of information in randomised basket trials2022
Dr Michael Grayling
Professor Rakesh Heer
Professor James Wason
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials2022
Dr Michael Grayling
Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials2022
Andrew Bryant
Dr Michael Grayling
Shaun Hiu
Eugenie Johnson
Professor Luke Vale
et al.
Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis2022
Dr Faye Williamson
Dr Michael Grayling
Professor James Wason
Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information2022
Aritra Mukherjee
Professor James Wason
Dr Michael Grayling
When is a two-stage single-arm trial efficient? An evaluation of the impact of outcome delay2022